MUNICH, February 24, 2016 /PRNewswire/ — Recognizing the immediate need for access to new therapeutic options for multidrug-resistant TB (MDR-TB), Otsuka Novel Products GmbH (Otsuka) today announced an ambitious new public-private partnership with the Stop TB Partnership (Stop TB) to increase access and scale-up treatment of delamanid (Deltyba™) in low- and middle-income countries. Any country […]

Swiss drugmaker Roche Holding has dropped out of a high-profile project to develop an antibiotic for treating “superbug” infections, the company said on Sunday.   Roche had agreed in 2013 to pay privately held partner Polyphor up to 500 million Swiss francs ($485.3 million) for rights to the product, marking a rare foray by a […]

A new gene that makes bacteria highly resistant to a last-resort class of antibiotics has been found in people and pigs in China – including in samples of bacteria with epidemic potential, researchers said on Wednesday. The discovery was described as “alarming” by scientists, who called for urgent restrictions on the use of polymyxins – […]

People across the world are alarmingly confused about the role of antibiotics and the right way to take them, and this ignorance is fuelling the rise of drug-resistant superbugs, the World Health Organization said on Monday. “The rise of antibiotic resistance is a global health crisis,” WHO Director-General Margaret Chan told reporters in a telebriefing […]

The U.S. Food and Drug Administration has ordered three Japanese manufacturers of duodenoscopes to conduct studies to evaluate how the devices are being used, as part of its effort to prevent the transmission of infections through the device. Duodenoscopes are flexible, lighted tubes inserted down the throat to drain fluids from blocked pancreatic and biliary […]